Otter Health, a healthcare technology startup focused on improving care quality and reducing unnecessary medical spending, has launched with $8 million in seed funding.
The round was co-led by Fika Ventures and Evidenced, with participation from Slow Ventures, Metrodora, CoFound Partners, Layout Ventures, Patient Capital, and Semper Virens.
The company is developing an AI-powered platform designed to help health insurers and healthcare providers make better decisions about patient care. Its technology aims to reduce unnecessary treatments and administrative work while helping clinicians follow evidence-based medical guidelines.
Otter Health’s platform integrates with a variety of electronic health record (EHR) systems so healthcare organizations and payers are able to view care decisions in real time. Instead of traditional prior authorization as a primary function, the platform offers continuous insights into clinical practice, peer benchmarking and opportunities for quality improvements and cost reductions.
Moving Beyond Traditional Prior Authorization
Prior authorization is a process through which health insurers review certain treatments or services before approving coverage. Although it is intended to help manage healthcare costs and ensure appropriate treatment, the process can create administrative work and delay patient care.
Otter Health provides a workaround by helping providers and insurers evaluate care decisions against clinical evidence and established guidelines. Its platform encompasses a wider scope of activities including referrals to specialists, outpatient procedures, treatment pathway compliance and transitions between care settings.
Otter Health’s mission is to give healthcare providers and payers a shared view of clinical performance so they can work together instead of being constrained by administration. The platform can identify low-value care, improve accountability and highlight potential savings.
AI Platform Targets Unnecessary Healthcare Spending
Otter Health says it is already working with multiple healthcare organizations across the payer and provider sectors. According to the company, its platform has helped participating organizations reduce non-evidence-based care decisions to less than 5% after removing prior authorization and introducing targeted engagement through its system.
The company also says its approach can identify savings from unnecessary care that traditional authorization processes may not capture.
The launch comes amid continued concerns about the administrative burden of prior authorization. According to figures cited by Otter Health from the American Medical Association, physicians complete nearly 40 prior authorizations per week. The company also cites survey findings that 93% of physicians report prior authorization delays necessary care, while 82% say it can cause patients to abandon treatment.
Otter Health estimates that over 60 percent of low-value healthcare spending is outside the traditional authorization controls. The paper suggests that considering a broader spectrum of clinical decisions could enable healthcare organizations to detect unnecessary expenditures without compromising appropriate patient care.
Funding to Support Healthcare Innovation
The $8 million in seed funding will help Otter Health expand its platform and partner with more healthcare organizations. This is particularly relevant in an era of value-based care models, which are shifting accountability for treatment outcomes and healthcare costs to providers.
Otter Health leverages AI, clinical evidence, and ongoing performance monitoring to bring together insurers and providers around the shared goal of providing the right care at the right cost.
The company’s overall strategy is to make utilization management more transparent and collaborative, helping healthcare organizations to move away from administrative processes that can create friction between payers and clinicians.
